A live, fully-cited GLP-1 reference.
GLPcompare is an informational data platform that tracks every GLP-1 medication and the supplements marketed alongside them, and cites the primary source behind every figure. It is a reference, not a pharmacy and not a clinic.
One page per drug, one source per number
The GLP-1 category moves fast: prices shift, products go in and out of shortage, new trials report, and the line between an FDA-approved medicine and a compounded or supplement product gets blurred in marketing. GLPcompare exists to make that landscape legible without spin. For each medication we show live shortage status, acquisition and cash prices, clinical-trial evidence, safety recalls, and FDA label facts, and we link each one to the exact record it came from.
We do the same for the "natural GLP-1" supplements. We show their real NIH label data and a verdict drawn from the primary literature, and we say plainly that none of them is a GLP-1 receptor agonist. The point is not to sell anything. The point is that you can check us.
The rules behind every number
Every figure traces to a source
Nothing here is a bare number. Each price, shortage status, trial count, and label fact links directly to the FDA, NLM, CMS, or NIH record that proves it. If we cannot name a source, we do not show the figure.
We rank by the data, and disclose every partner
GLPcompare compares by the underlying data (price, shortage status, evidence), and a partner never changes a price or a fact. Partner status and commission rates contribute to offer and provider value scores and can affect their order. Every partner is labeled. A value score is not a medical recommendation or a guarantee of the lowest price. We show a figure only when we have a real source for it; when we do not, we show an honest gap, never an invented number.
We stamp when we retrieved it
Live data carries its own retrieval time, so you can see how fresh it is. Compounded and cash prices are labeled and never presented as an FDA-approved list price.
Only primary regulatory and clinical sources
We build on authoritative, mostly free and open government data. Every dataset below is public, and each figure on the site links back to it.
Drug labels, live shortage status, recalls, and post-market safety, through openFDA and MedWatch.
DailyMed labels, RxNorm drug identity, ClinicalTrials.gov, PubMed, and PubChem chemistry.
NADAC acquisition cost and Part D spending: neutral, government pricing benchmarks.
The Dietary Supplement Label Database (DSLD): real label facts for the 'natural GLP-1' market.
No named clinician, no fabricated history
Every figure on GLPcompare is drawn from primary sources (the FDA, the U.S. National Library of Medicine, CMS, and the NIH Office of Dietary Supplements) and links back to the record that proves it. Literature counts link to the exact Europe PMC searches and describe research activity, not evidence quality. We publish what the sources say, cite where it came from, and stamp when we retrieved it.
Published by GLPcompare Editorial. We do not invent a clinician byline, a team page, or a founding story to borrow authority we have not earned. The authority here comes from the sources: they are named, dated, and one click away on every figure.
Editorial catalog and methodology as of 2026-09-30. Live data carries its own retrieval time.